Congress Asset Management CO Moon Lake Immunotherapeutics Transaction History
Congress Asset Management CO
- $14.3 Billion
- Q3 2024
A detailed history of Congress Asset Management CO transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Congress Asset Management CO holds 66,641 shares of MLTX stock, worth $3.32 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
66,641Holding current value
$3.32 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding MLTX
# of Institutions
127Shares Held
58.1MCall Options Held
102KPut Options Held
75.9K-
Bvf Inc San Francisco, CA21.8MShares$1.08 Billion29.25% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$424 Million28.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$138 Million1.66% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.56MShares$128 Million0.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.27MShares$113 Million0.02% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.84B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...